| Annual Financials | 2015 | 2016 | TTM |
Revenue  | 171 | 192 | 0 |
| Expenses | 143 | 156 | 0 |
| EBITDA | 28 | 37 | 0 |
| Operating Profit % | 14 % | 16 % | 0 % |
| Depreciation | 3 | 3 | 0 |
| Interest | 1 | 0 | 0 |
| Profit Before Tax | 24 | 32 | 0 |
| Tax | 9 | 12 | 0 |
| Net Profit | 15 | 21 | 0 |
| EPS in ₹ | 10.31 | 14.08 | 0.00 |
Amrutanjan Health Care
Amrutanjan Health Care
680.95
-0.60
(-0.09%)
Market Cap
₹1,968.67 Cr
PE Ratio
35.70
Volume
4,185.00
Day High - Low
₹684.70 - ₹679.00
52W High-Low
₹842.90 - ₹544.10
Key Fundamentals
Market Cap
1,968.67 Cr
EPS
14.08
PB Ratio
5.92
Book Value
118.32
EBITDA
36.50
Dividend Yield
0.66 %
Industry
Healthcare Sector
Pharmaceuticals ROE Growth %
-
Debt to Equity
0.02
Actual
Company News
View All News
Amrutanjan Healthcare Reports 7.08% Revenue Growth in Q2FY26 with Strong Pain Management Segment Performance
Nov 11, 2025
Nov 11, 2025Amrutanjan Healthcare Limited reported net sales of Rs. 117.70 crores in Q2FY26, representing 7.08% growth compared to Rs. 109.92 crores in Q2FY25. Profit before tax increased 20.51% to Rs. 19.21 crores, while profit after tax grew 14.23% to Rs. 15.94 crores. For H1FY26, net sales reached Rs. 211.75 crores (9.35% growth) with profit before tax rising 36.88% to Rs. 30.51 crores. The pain management segment showed strong performance with overall pain category growing 16% and body category achieving 21% growth. Key growth drivers included Maha Strong (31% growth), Back Pain Roll On (26% growth), and Head Roll On (42% growth). The company's OTC segment generated Rs. 112.80 crores in Q2FY26, while the beverages segment recorded Rs. 4.29 crores (26.55% growth). Comfy brand sales remained flat at Rs. 32.78 crores due to changes in quantity purchase scheme accounting. The company plans to launch premium sanitary pads and revive the JIFFY analgesic brand with Diclofenac topical range. A new sanitary napkin plant is expected to be commissioned by late Q4.
Amrutanjan Healthcare Limited has fixed November 18, 2025 as the record date for payment of its first interim dividend for the financial year 2025-26. The dividend will be paid to members whose names appear in the register of members and as beneficial owners as per details from NSDL and CDSL on the record date. The company has informed NSE and BSE about this decision.
Amrutanjan Health Care delivered robust quarterly performance with net profit rising to 139.6 million rupees from 117.9 million rupees year-over-year. Revenue increased to 1.18 billion rupees compared to 1.1 billion rupees in the same period last year. EBITDA grew to 165.2 million rupees from 136 million rupees, while EBITDA margin expanded to 14.04% from 12.38% year-over-year, indicating improved operational efficiency alongside revenue growth.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,831.60 | #1 4,39,462.19 | 40.68 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 79.43 | |
6,477.00 | 1,71,944.00 | 69.05 | 9,712.00 | 18.67 | 2,191 | 35.10 | 49.62 | |
3,720.60 | 1,25,922.01 | 58.80 | 11,539.40 | 6.99 | 1,911 | 30.46 | 53.11 | |
1,531.30 | 1,23,691.38 | 22.73 | 28,409.50 | 7.12 | 5,291 | 3.71 | 50.63 | |
1,258.80 | 1,05,061.18 | #1 18.15 | 33,741.20 | 16.73 | 5,725 | -0.38 | 57.24 | |
2,082.20 | 95,105.43 | 21.34 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 65.07 | |
942.50 | 94,837.55 | 18.56 | 23,511.00 | 18.55 | 4,615 | 34.60 | 44.36 | |
2,251.00 | 92,911.94 | 52.05 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 38.76 | |
1,226.70 | 71,246.94 | 20.70 | 32,345.60 | 9.43 | 3,484 | 3.81 | 63.81 | |
5,685.00 | 67,972.70 | 28.29 | 13,458.30 | 3.70 | 2,216 | 10.98 | 53.82 |
Growth Rate
Revenue Growth
12.51 %
Net Income Growth
38.26 %
Cash Flow Change
13.01 %
ROE
20.51 %
ROCE
15.30 %
EBITDA Margin (Avg.)
15.48 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 |
| Total Assets | 124 | 140 |
| Fixed Assets | 24 | 29 |
| Current Assets | 83 | 101 |
| Capital Work in Progress | 4 | 1 |
| Investments | 0 | 0 |
| Other Assets | 96 | 111 |
| Total Liabilities | 124 | 140 |
| Current Liabilities | 26 | 28 |
| Non Current Liabilities | 3 | 4 |
| Total Equity | 95 | 109 |
| Reserve & Surplus | 92 | 106 |
| Share Capital | 3 | 3 |
Cash Flow
| Cash Flow | 2015 | 2016 |
| Net Cash Flow | 2 | 12 |
| Investing Activities | -5 | 4 |
| Operating Activities | 18 | 21 |
| Financing Activities | -12 | -13 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 50.02 % | 50.02 % | 50.02 % | 50.02 % | 50.02 % | 50.02 % | 50.02 % | 50.02 % | 50.04 % | 50.04 % | 50.59 % | 50.59 % | 50.59 % | 50.59 % | 46.52 % | 46.52 % | 46.52 % | 46.52 % | 46.52 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.75 % | 0.00 % | 1.38 % | 1.55 % | 2.34 % | 2.30 % | 2.30 % | 2.41 % | 2.38 % |
| DIIs | 7.42 % | 7.16 % | 6.82 % | 6.01 % | 6.01 % | 6.03 % | 6.30 % | 6.39 % | 7.18 % | 7.22 % | 7.10 % | 6.88 % | 7.29 % | 7.32 % | 10.60 % | 11.12 % | 11.41 % | 12.70 % | 12.90 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 33.69 % | 34.56 % | 35.12 % | 35.63 % | 35.91 % | 35.64 % | 36.09 % | 35.99 % | 35.38 % | 35.03 % | 35.00 % | 34.61 % | 34.17 % | 33.87 % | 34.09 % | 33.73 % | 33.56 % | 32.28 % | 32.18 % |
| Others | 8.87 % | 8.25 % | 8.03 % | 8.33 % | 8.05 % | 8.31 % | 7.59 % | 7.60 % | 7.41 % | 7.71 % | 6.57 % | 7.92 % | 6.57 % | 6.67 % | 6.45 % | 6.33 % | 6.22 % | 6.09 % | 6.02 % |
| No of Share Holders | 29,474 | 33,717 | 41,640 | 61,367 | 67,323 | 66,173 | 71,064 | 72,104 | 69,947 | 71,428 | 72,002 | 68,404 | 62,664 | 57,169 | 54,536 | 53,856 | 51,674 | 49,431 | 47,954 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 3.85 | 3.05 | 2.15 | 2.1 | 4.2 | 4.6 | 4.6 | 4.6 | 4.6 |
| Dividend Yield (%) | 0.00 | 1.42 | 0.99 | 0.65 | 0.37 | 0.53 | 0.8 | 0.74 | 0.71 | 0.67 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 19 Feb 2021 |  Dividend | ₹ 0.80 /share | 17 Feb 2021 | 526.95 | 569.90 |
| 16 Sept 2021 | Dividend | ₹ 2.60 /share | 15 Sept 2021 | 797.60 | 733.45 |
| 17 Nov 2021 | Dividend | ₹ 1.00 /share | 16 Nov 2021 | 993.60 | 930.45 |
| 21 Feb 2022 | Dividend | ₹ 1.00 /share | 18 Feb 2022 | 838.85 | 789.85 |
| 16 Sept 2022 | Dividend | ₹ 2.60 /share | 14 Sept 2022 | 846.25 | 751.30 |
| 22 Sept 2022 |  Annual General Meeting | NA | 22 Sept 2022 | 768.40 | 724.20 |
| 15 Nov 2022 | Dividend | ₹ 1.00 /share | 14 Nov 2022 | 731.25 | 736.75 |
| 24 Feb 2023 | Dividend | ₹ 1.00 /share | 24 Feb 2023 | 711.75 | 606.95 |
| 14 Sept 2023 | Dividend | ₹ 2.60 /share | 14 Sept 2023 | 599.05 | 628.90 |
| 21 Sept 2023 | Annual General Meeting | NA | 21 Sept 2023 | 648.75 | 629.65 |
| 23 Nov 2023 | Dividend | ₹ 1.00 /share | 23 Nov 2023 | 607.55 | 602.65 |
| 20 Feb 2024 | Dividend | ₹ 1.00 /share | 20 Feb 2024 | 582.40 | 652.25 |
| 17 Sept 2024 | Dividend | ₹ 2.60 /share | 13 Sept 2024 | 729.50 | 785.60 |
| 23 Sept 2024 | Annual General Meeting | NA | 23 Sept 2024 | 755.35 | 799.85 |
| 12 Nov 2024 |  Quarterly Result Announcement | NA | 12 Nov 2024 | 761.80 | 700.10 |
| 22 Nov 2024 | Dividend | ₹ 1.00 /share | 22 Nov 2024 | 700.10 | 705.50 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 665.85 | 631.90 |
| 18 Feb 2025 | Dividend | ₹ 1.00 /share | 18 Feb 2025 | 631.90 | 602.85 |
| 15 May 2025 | Quarterly Result Announcement | NA | 15 May 2025 | 679.40 | 716.45 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 686.90 | 656.50 |
| 16 Sept 2025 | Dividend | ₹ 2.60 /share | 16 Sept 2025 | 716.45 | 761.70 |
| 23 Sept 2025 | Annual General Meeting | NA | 23 Sept 2025 | 656.50 | 759.40 |
| 10 Nov 2025 | Quarterly Result Announcement | NA | 10 Nov 2025 | 717.35 | 707.85 |
| 18 Nov 2025 | Dividend | ₹ 1.00 /share | 18 Nov 2025 | 707.85 | 710.40 |
Announcements
Investor Presentation For The Quarter Ended 30Th September 2025Nov 11, 2025
Nov 11, 2025Record Date For The First Interim Dividend Is 18 November 2025.Nov 10, 2025
Nov 10, 2025Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025Nov 10, 2025
Nov 10, 2025Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results Along With The Limited Review Report For The Quarter Ended 30Th September 2025 And Declaration Of The 1St Interim DividendNov 04, 2025
Nov 04, 2025Disclosure Under Regulation 30 Of SEBI LODR 2015Oct 18, 2025
Oct 18, 2025Product LaunchOct 14, 2025
Oct 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 24, 2025
Sep 24, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 24, 2025
Sep 24, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 23, 2025
Sep 23, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 23, 2025
Sep 23, 2025Monthly Update: Re-Lodgement Of Transfer Request Of Physical SharesSep 15, 2025
Sep 15, 2025Initmation Regarding Special Window For Relodgement Of SharesSep 15, 2025
Sep 15, 2025Reg. 34 (1) Annual Report.Sep 05, 2025
Sep 05, 2025Corrigendum To Annual Report For The Financial Year 2024-2025Sep 05, 2025
Sep 05, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 29, 2025
Aug 29, 2025Reg. 34 (1) Annual Report.Aug 29, 2025
Aug 29, 202588Th Annual General Meeting Of The Company To Be Held On 23Rd September 2025.Aug 29, 2025
Aug 29, 2025Initmation Regarding 100 Days Campaign - Saksham NiveshakAug 28, 2025
Aug 28, 2025Initmation Regarding 100 Days Campaign - Saksham NiveshakAug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 13, 2025
Aug 13, 2025Record Date For The Final Dividend Is 16 September 2025.Aug 12, 2025
Aug 12, 2025Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30 2025Aug 12, 2025
Aug 12, 2025Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results For The Quarter Ended 30Th June 2025Aug 06, 2025
Aug 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Jul 07, 2025Closure of Trading WindowJun 23, 2025
Jun 23, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 21, 2025
May 21, 2025Investor Presentation For The Quarter And Year Ended 31St March 2025May 19, 2025
May 19, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 15, 2025
May 15, 2025Integrated Filing (Financial)May 15, 2025
May 15, 2025Board Meeting Outcome for Financial Results And Dividend For The Year Ended March 31 2025.May 15, 2025
May 15, 2025Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended 31St March 2025
Recommendation Of Final Dividend For The Year 2024-25May 08, 2025
May 08, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2025
Apr 29, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Disclosure Under Regulation 30 Of SEBI LODR 2015Mar 03, 2025
Mar 03, 2025Disclosure Under Regulation 30 Of SEBI LODR 2015Mar 03, 2025
Mar 03, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2025
Feb 14, 2025Intimation Of Record Date For The Second Interim Dividend.Feb 12, 2025
Feb 12, 2025Integrated Filing (Financial)Feb 12, 2025
Feb 12, 2025Unaudited Financial Results For The Quarter Ended December 31 2024.Feb 12, 2025
Feb 12, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On February 12 2025.Feb 12, 2025
Feb 12, 2025Board Meeting Intimation for Unaudited Finacial Results For The Quarter Ended 31St December 2024 And 2Nd Interim DividendJan 31, 2025
Jan 31, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Jan 07, 2025Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 13, 2024
Dec 13, 2024Intimation Of Revised Record Date For The Purpose Of 1St Interim Dividend For FY 2024-25.Nov 14, 2024
Nov 14, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2024
Nov 14, 2024Announcement under Regulation 30 (LODR)-Investor PresentationNov 13, 2024
Nov 13, 2024Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 DSP Small Cap Direct Plan-Growth | 0.63% | 0 | 0.00% | 0.02% | |
 ICICI Prudential FMCG Direct-Growth | 2.65% | 0 | 0.05% | 0.27% | |
 Sundaram Small Cap Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% |
Technical Indicators
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
